Study of Probuphine in Patients With Opioid Dependence

NCT00772785 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated for reasons not related to efficacy or safety

Conditions

Opioid Dependency

Interventions

DRUG: Probuphine (buprenorphine implant)

Sponsor

Titan Pharmaceuticals